Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review

Daniele De Luca, P Cogo, Enrico Zecca, Marco Piastra, Domenico Pietrini, A Tridente, Guido Conti, Vp Carnielli

Risultato della ricerca: Contributo in rivistaArticolo in rivista

24 Citazioni (Scopus)


Administration of drugs directly into the respiratory tree first was proposed a long time ago. Surfactant is the paradigmatic example of such therapies. Many other drugs have been used in the same way and further compounds are under investigation for this aim. In the last two decades, despite the wide number of drugs available for direct lung administration in critical care patients, few controlled data exist regarding their use in neonates and infants. This review will focus on drugs clinically available in a critical care setting for neonates and infants, including bronchodilators, pulmonary vasodilators, anti-inflammatory agents, mucolytics, resuscitative anti-infective agents, surfactants and other drugs. We provide an evidence-based comprehensive review of drugs available for intratracheal administration in paediatric and neonatal critical care and we examine possible advantages and risks for each proposed indication.
Lingua originaleEnglish
pagine (da-a)678-689
Numero di pagine12
RivistaEuropean Respiratory Journal
Stato di pubblicazionePubblicato - 2011


  • Administration, Inhalation
  • Adrenergic beta-2 Receptor Agonists
  • Bronchodilator Agents
  • Child
  • Cholinergic Antagonists
  • Critical Care
  • Epinephrine
  • Evidence-Based Medicine
  • Gases
  • Humans
  • Intensive Care, Neonatal
  • Nitric Oxide
  • Prostaglandins I
  • Respiratory System
  • S-Nitrosothiols
  • Steroids
  • Surface-Active Agents


Entra nei temi di ricerca di 'Intrapulmonary drug administration in neonatal and paediatric critical care: a comprehensive review'. Insieme formano una fingerprint unica.

Cita questo